SCHEMBL346655

SCHEMBL346655

O=C(Nc1ccc(C(=O)N2CCN(Cc3nc(C(=O)NC4CCC4)co3)CC2)cc1)NC1CCC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PRKAA2 P54646 11/20 0.46
PRKAB2 O43741 6/20 0.46
PRKAG1 P54619 6/20 0.46
PRKAA1 Q13131 6/20 0.46
PRKAG3 Q9UGI9 6/20 0.46
PRKAG2 Q9UGJ0 6/20 0.46
PRKAB1 Q9Y478 6/20 0.46
KMT2A Q03164 2/20 0.43
HRH3 Q9Y5N1 1/20 0.43
EPHX2 P34913 3/20 0.42
NAMPT P43490 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
EPHX1 P07099 1/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL348092 0.93 PRKAA2 (0.43) PRKAA2PRKAB2PRKAG1PRKAA1PRKAG3
SCHEMBL10077357 0.92 KMT2A (0.41) PRKAA2PRKAB2PRKAG1PRKAA1PRKAG3
SCHEMBL347914 0.90 EPHX2 (0.48) KMT2AHRH3EPHX2NPC1RAB9A
SCHEMBL1839277 0.88 KMT2A (0.45) KMT2AEPHX2NPC1RAB9AEPHX1
Trifluoroacetic Acid SCHEMBL347844 0.88 EPHX2 (0.44) PRKAA2PRKAB2PRKAG1PRKAA1PRKAG3
Trifluoroacetic Acid SCHEMBL346884 0.87 EPHX2 (0.41) PRKAA2PRKAB2PRKAG1PRKAA1PRKAG3
SCHEMBL347845 0.86 EPHX2 (0.46) PRKAA2PRKAB2PRKAG1PRKAA1PRKAG3
Trifluoroacetic Acid SCHEMBL15310321 0.85 EPHX2 (0.40) KMT2AHRH3EPHX2
SCHEMBL348445 0.76 KMT2A (0.43) PRKAA2PRKAB2PRKAG1PRKAA1PRKAG3
SCHEMBL1020858 0.74 EPHX1 (0.56) KMT2AEPHX2NPC1RAB9AEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8759352-B2 1-(4-ureidobenzoyl)piperazine derivatives MERCK SHARP & DOHME B.V. (NL) 2014-06-24 US disclosed
EP-2318368-B1 1-(4-UREIDOBENZOYL)PIPERAZINE DERIVATIVES MERCK SHARP & DOHME (NL) 2013-10-16 EP disclosed
US-20120015958-A1 1-(4-UREIDOBENZOYL)PIPERAZINE DERIVATIVES N.V. ORGANON (NL) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015958-A1 1-(4-UREIDOBENZOYL)PIPERAZINE DERIVATIVES NPC1, ABCB11, NPC1L1 PRKAA2 4031/4885PRKAB2 4576/4885PRKAG1 4577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.